Steward Partners Investment Advisory’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.19M | Buy |
4,162
+1,005
| +32% | +$564K | 0.01% | 872 |
|
|
2026
Q1 | $1.77M | Sell |
3,157
-600
| -16% | -$385K | 0.01% | 906 |
|
|
2025
Q4 | $2.54M | Sell |
3,757
-114
| -3% | -$77.6K | 0.01% | 690 |
|
|
2025
Q3 | $2.47M | Buy |
3,871
+11
| +0.3% | +$6.68K | 0.01% | 697 |
|
|
2025
Q2 | $2.07M | Buy |
3,860
+1,165
| +43% | +$557K | 0.02% | 707 |
|
|
2025
Q1 | $1.13M | Buy |
2,695
+259
| +11% | +$112K | 0.01% | 870 |
|
|
2024
Q4 | $1.01M | Buy |
2,436
+218
| +10% | +$95.6K | 0.01% | 872 |
|
|
2024
Q3 | $1.12M | Buy |
2,218
+585
| +36% | +$284K | 0.01% | 816 |
|
|
2024
Q2 | $796K | Buy |
1,633
+39
| +2% | +$19.6K | 0.01% | 889 |
|
|
2024
Q1 | $861K | Buy |
1,594
+176
| +12% | +$96.2K | 0.01% | 849 |
|
|
2023
Q4 | $787K | Sell |
1,418
-8
| -0.6% | -$3.76K | 0.01% | 812 |
|
|
2023
Q3 | $624K | Buy |
1,426
+57
| +4% | +$28.4K | 0.01% | 847 |
|
|
2023
Q2 | $688K | Buy |
1,369
+35
| +3% | +$16.8K | 0.01% | 816 |
|
|
2023
Q1 | $667K | Sell |
1,334
-72
| -5% | -$34.5K | 0.01% | 818 |
|
|
2022
Q4 | $574K | Sell |
1,406
-1
| -0.1% | -$388 | 0.01% | 852 |
|
|
2022
Q3 | $458K | Sell |
1,407
-6
| -0.4% | -$2.2K | 0.01% | 882 |
|
|
2022
Q2 | $496K | Buy |
1,413
+296
| +26% | +$121K | 0.01% | 852 |
|
|
2022
Q1 | $611K | Buy |
1,117
+66
| +6% | +$34.7K | 0.01% | 856 |
|
|
2021
Q4 | $692K | Buy |
1,051
+697
| +197% | +$438K | 0.01% | 829 |
|
|
2021
Q3 | $220K | Buy |
354
+52
| +17% | +$34.9K | ﹤0.01% | 1234 |
|
|
2021
Q2 | $191K | Sell |
302
-129
| -30% | -$71.2K | ﹤0.01% | 1579 |
|
|
2021
Q1 | $211K | Buy |
431
+226
| +110% | +$113K | ﹤0.01% | 1275 |
|
|
2020
Q4 | $102K | Buy |
205
+101
| +97% | +$45.2K | ﹤0.01% | 1352 |
|
|
2020
Q3 | $41K | Buy |
104
+2
| +2% | +$739 | ﹤0.01% | 1584 |
|
|
2020
Q2 | $34K | Buy |
102
+62
| +155% | +$18K | ﹤0.01% | 1570 |
|
|
2020
Q1 | $9K | Hold |
40
| – | – | ﹤0.01% | 1901 |
|
|
2019
Q4 | $10K | Hold |
40
| – | – | ﹤0.01% | 2011 |
|
|
2019
Q3 | $10K | Sell |
40
-3
| -7% | -$835 | ﹤0.01% | 1985 |
|
|
2019
Q2 | $11K | Buy |
+43
| New | +$10.6K | ﹤0.01% | 1939 |
|
|
2018
Q4 | – | Sell |
-43
| Closed | -$11K | – | 1406 |
|
|
2018
Q3 | $11K | Buy |
43
+3
| +8% | +$728 | ﹤0.01% | 1837 |
|
|
2018
Q2 | $9K | Hold |
40
| – | – | ﹤0.01% | 1778 |
|
|
2018
Q1 | $7K | Hold |
40
| – | – | ﹤0.01% | 1692 |
|
|
2017
Q4 | $6K | Hold |
40
| – | – | ﹤0.01% | 1464 |
|
|
2017
Q3 | $6K | Hold |
40
| – | – | ﹤0.01% | 1242 |
|
|
2017
Q2 | $6K | Hold |
40
| – | – | ﹤0.01% | 1172 |
|
|
2017
Q1 | $6K | Buy |
+40
| New | +$5.51K | ﹤0.01% | 1072 |
|
Other funds holding IDXX
Steward Partners Investment Advisory's IDXX Position: Q2 2026 in Review
Steward Partners Investment Advisory increased its Idexx Laboratories (IDXX) stake by 32% in Q2 2026, buying an estimated $564K and bringing the position to 4,162 shares worth $2.19M. The position accounts for 0.01% of the portfolio, ranked #872.
Steward Partners Investment Advisory first reported a position in IDXX in Q1 2017 and has held it in 36 quarters since. The position peaked at $2.54M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Steward Partners Investment Advisory held 4,162 shares of Idexx Laboratories worth $2.19M as of Q2 2026.
- Steward Partners Investment Advisory bought 1,005 Idexx Laboratories shares in Q2 2026, an estimated $564K.
- Idexx Laboratories made up 0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #872 holding.
- Steward Partners Investment Advisory first reported a position in Idexx Laboratories in Q1 2017 and has held it in 36 quarters since.
- Steward Partners Investment Advisory's Idexx Laboratories position peaked at $2.54M in Q4 2025.
- 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.